Critical evaluation of the off-label indication and of the risks associated to the use of multi-dose vials on the treatment of age-related macular degeneration . Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 50, n. 1, p. 63–72, 2014. DOI: 10.1590/S1984-82502011000100006. Disponível em: https://revistas.usp.br/bjps/article/view/80851.. Acesso em: 13 may. 2024.